Consun Pharmaceutical Group Limited (HKG:1681)
13.60
-0.06 (-0.44%)
Aug 21, 2026, 4:08 PM HKT
HKG:1681 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, HKG:1681 stock has a consensus rating of "Buy" and an average price target of $23.88. The average 1-year stock price forecast is 75.59% higher than the current stock price, while the lowest is $21.70 (+59.56%) and the highest is $26.73 (+96.54%).
Price Target: $23.88 (+75.59%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 2, 2026.
Analyst Ratings
The average analyst rating for HKG:1681 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | Aug '25 | Sep '25 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst China Everbright No rating | China Everbright | Buy Maintains $17.73 | Buy | Maintains | $17.73 | +30.37% | Jul 2, 2026 |
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $21.40 | Buy | Maintains | $21.40 | +57.35% | Apr 23, 2026 |
Unknown Analyst First Shanghai Securities No rating | First Shanghai Securities | Buy Maintains $25.30 | Buy | Maintains | $25.30 | +86.03% | Apr 16, 2026 |
| DBS | DBS | Buy Maintains $26.00 | Buy | Maintains | $26.00 | +91.18% | Mar 27, 2026 |
Financial Forecast
Revenue This Year
3.88B
from 3.42B
Increased by 13.60%
Revenue Next Year
4.35B
from 3.88B
Increased by 12.07%
EPS This Year
1.47
from 1.26
Increased by 16.89%
EPS Next Year
1.62
from 1.47
Increased by 10.07%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.